The deal size was increased to 27M shares from 20M and priced below last closing price of $0.42. Alliance Global Partners is acting as sole book running manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVPH:
- Reviva Pharmaceuticals announces common stock, warrants offering
- Reviva Pharmaceuticals price target lowered to $7 from $14 at Benchmark
- Reviva Pharmaceuticals Advances Schizophrenia Treatment
- Reviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
- Reviva Pharmaceuticals price target lowered to $3 from $7 at Roth Capital